Dysregulation of <i>Col8a1</i> and <i>Col8a2</i> is implicated in a broad spectrum of disorders, including vascular remodeling, tissue fibrosis, diabetic nephropathy, cancer progression, and corneal endothelial dystrophies. This evidence concerns the gene COL8A2 and cancer.